People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

106.54USD
29 Sep 2014
Price Change (% chg)

$-0.56 (-0.52%)
Prev Close
$107.10
Open
$106.24
Day's High
$106.65
Day's Low
$106.04
Volume
2,218,528
Avg. Vol
1,862,189
52-wk High
$108.77
52-wk Low
$85.50

Search Stocks

McClellan, Mark 

Brief Biography

Dr. Mark B. McClellan, M.D., Ph.D. is a Independent Director of Johnson & Johnson. As former commissioner of the U.S. Food and Drug Administration (FDA) from 2002 to 2004, and as the former administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006, Dr. McClellan has more than two decades of public service and academic research experience. From 2001 to 2002, he served as a member of the President's Council of Economic Advisers and senior director for health care policy at the White House. During President William J. Clinton's administration, Dr. McClellan held the position of deputy assistant secretary of the Treasury for economic policy. While at FDA, Dr. McClellan implemented the Critical Path Initiative, regulatory reforms to modernize pharmaceutical manufacturing, and new initiatives on food safety and security. He has also led the development of performance-based health care payment reforms, insurance coverage reforms, and a range of public-private initiatives to help improve care and lower costs. Dr. McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research. Among other well-known health organizations in which he holds positions, he is the Chair of the Clinician Measure Applications Partnership for the National Quality Forum. Dr. McClellan has received the Kenneth J. Arrow Award twice for Outstanding Research in Health Economics. A 1985 graduate of the University of Texas at Austin, Dr. McClellan earned his MD degree at the Harvard University-Massachusetts Institute of Technology (MIT) Division of Health Science and Technology, and his MPA at the Kennedy School of Government at Harvard. He earned his PhD in Economics at MIT and completed his residency in internal medicine at Brigham and Women's Hospital in Boston.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

16,911,000

Dominic Caruso

8,233,320

Sandra Peterson

5,637,260

Paulus Stoffels

7,822,000

Michael Ullmann

4,363,340

Peter Fasolo

3,621,280
As Of 28 Dec 2013
Search Stocks